Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/2003
07/23/2003EP1329508A1 Novel g protein-coupled receptor protein and dna thereof
07/23/2003EP1329507A1 Artificial protein having potentiated immunogenicity of epitope
07/23/2003EP1329504A1 Nucleic acid of novel human kinesin-associated gene, protein encoded by the nucleic acid, peptide fragment thereof and anticancer agents comprising the nucleic acid and the like
07/23/2003EP1329503A1 Sphingolipid ceramide deacylase gene
07/23/2003EP1329501A1 Novel pla1
07/23/2003EP1329499A2 Growth factor-responsive progenitor cells which can be proliferated in vitro
07/23/2003EP1329461A1 Method of eliminating human serum albumin polymers
07/23/2003EP1329459A2 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
07/23/2003EP1329458A2 Peptides that lower blood glucose levels
07/23/2003EP1329457A2 Antipicornaviral compounds, their preparation and use
07/23/2003EP1329224A1 Solution formulations having long-term stability
07/23/2003EP1329223A1 Expression potentiator for protein synthesis regulatory gene
07/23/2003EP1329221A1 Polymeric micelle containing cisplatin enclosed therein and use thereof
07/23/2003EP1328816A2 Regulation of neutral development by daedalos
07/23/2003EP1328807A2 Use of vanilloid 4 receptor and antagonists or agonists thereof for treating diseases associated with pain
07/23/2003EP1328662A2 Flea peritrophin nucleic acid molecules, proteins and uses thereof
07/23/2003EP1328656A1 Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents
07/23/2003EP1328653A2 Highly expressible genes
07/23/2003EP1328641A2 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof
07/23/2003EP1328637A2 Regulation of human secretin receptor-like gpcr
07/23/2003EP1328636A2 Nucleic acids and polypeptides
07/23/2003EP1328634A2 Genes expressed in the cell cycle
07/23/2003EP1328633A2 Human ion channel proteins and polynucleotides encoding the same
07/23/2003EP1328631A2 Her-2/neu fusion proteins
07/23/2003EP1328630A2 Secreted proteins
07/23/2003EP1328625A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof
07/23/2003EP1328624A2 B7-like molecules and uses thereof
07/23/2003EP1328623A2 Human proteases and polynucleotides encoding the same
07/23/2003EP1328622A2 Protein c or activated protein c-like molecules
07/23/2003EP1328621A2 13245, a novel human myotonic dystrophy type protein kinase and uses therefor
07/23/2003EP1328620A1 Compositions and methods for delaying, preventing, rejuvenating or reversing senescence in cells
07/23/2003EP1328619A1 Human tuberoinfundibular peptide of 39 residues
07/23/2003EP1328549A1 Human prostate specific g-protein receptor hpraj70
07/23/2003EP1328547A1 Identification and modification of immunodominant epitopes in polypeptides
07/23/2003EP1328546A2 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator
07/23/2003EP1328545A1 Human gene critical to fertility
07/23/2003EP1328542A1 Von willebrand factor-binding proteins from staphylococci
07/23/2003EP1328539A1 Vegf peptides and their use for inhibiting angiogenesis
07/23/2003EP1328537A1 Antisense modulation of bh3 interacting domain death agonist expression
07/23/2003EP1328536A1 Antisense modulation of glioma-associated oncogene-1 expression
07/23/2003EP1328320A2 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination
07/23/2003EP1328298A1 Methods and compositions for modulating t cell activation and uses thereof
07/23/2003EP1328297A2 The function of a haptoglobin-haemoglobin receptor and the uses thereof
07/23/2003EP1328295A2 New interferon beta-like molecules
07/23/2003EP1328289A2 Oxidized proteins, their biological activity, and therapeutic and diagnostic measures, which are derived from the active mechanism, from the use of these proteins or from the inhibition thereof
07/23/2003EP1328288A2 Protein mixtures for wound healing
07/23/2003EP1328287A1 Compositions and methods for wt1 specific immunotherapy
07/23/2003EP1328286A1 Bone health compositions derived from milk
07/23/2003EP1328271A2 Method for the treatment of neurological and neuropsychological disorders
07/23/2003EP1328270A2 Method for the treatment of neurological and neuropsychological disorders
07/23/2003EP1328267A2 Method of treating cancer using dithiocarbamate derivatives
07/23/2003EP1328265A2 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions
07/23/2003EP1328258A1 A controlled-release, parenterally administrable microparticle preparation
07/23/2003EP1328253A2 Administration of a thiol-based chemoprotectant compound
07/23/2003EP1328234A4 Methods for treating cystic fibrosis
07/23/2003EP1328234A1 Methods for treating cystic fibrosis
07/23/2003EP1328151A2 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
07/23/2003EP1223972B1 Suspension of an epi-hne protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses
07/23/2003EP1154785B1 Inhibitors for use in hemostasis and immune function
07/23/2003EP1140199B1 Hyaluronate lyase used for promoting penetration in topical agents
07/23/2003EP1089753B1 Use of a dipeptide for stimulating repair processes
07/23/2003EP1079818B1 Composition comprising il-18 and topotecan for treatment and/or prevention of cancer
07/23/2003EP1077717B1 Use of lipopeptides or lipoproteins for wound treatment
07/23/2003EP1053012B1 Pharmaceutical compositions comprising peg-asparaginase for the treatment of hiv infections
07/23/2003EP1019078B1 Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis
07/23/2003EP1017711B1 Monocyclic compounds with four bifunctional residues having nk-2 antagonist action
07/23/2003EP1011716B1 Neuromedin b receptor antagonists
07/23/2003EP0956033B1 Total synthesis of the amino hip analogue of didemnin a
07/23/2003EP0951294B1 Method of producing concentrated non-buffered solutions of fibronectin
07/23/2003EP0914166B1 Methods of terminal sterilization of biological products
07/23/2003EP0874640B1 Cyclosporin formulation
07/23/2003EP0871665B1 Insulin derivatives
07/23/2003EP0871476B1 Dried blood factor composition comprising trehalose
07/23/2003EP0838223B1 Brain edema inhibitor
07/23/2003EP0820290B1 Use of vitamin d 2 or vitamin d 4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism
07/23/2003EP0814827B1 Vascular endothelial growth factor-b
07/23/2003EP0756630B1 Recombinant pgp3, methods of preparation and use in diagnosis and therapy
07/23/2003EP0743958B1 Avidin-biotin immunoconjugates
07/23/2003EP0714408B1 Tryptase inhibitor
07/23/2003EP0648226B1 NATURAL HUMAN IgM ANTIBODIES
07/23/2003EP0643770B1 Helicobacter pylori cytotoxin associated immunodominant antigen useful for vaccines and diagnostics
07/23/2003EP0586607B1 HEREGULINS (HRGs), BINDING PROTEINS OF P185?erb2
07/23/2003CN1432064A Bi-functional cancer treatment agents
07/23/2003CN1432062A Novel protein and gene encoding same
07/23/2003CN1432024A Immunodominant acetylcholine receptor alpha subunit peptides
07/23/2003CN1432023A Reductive alkylation process on glycopeptides
07/23/2003CN1432022A Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties
07/23/2003CN1431998A Growth hormone secretagogues
07/23/2003CN1431995A Antipicornaviral compounds and compsns. their pharmaceutical uses, and materials for their synthesis
07/23/2003CN1431941A 挤压模 Extrusion die
07/23/2003CN1431919A Device and liquid formulations
07/23/2003CN1431912A Combination product comprising melagatran and factor Xa inhibitor
07/23/2003CN1431911A Transgenically produced decorin
07/23/2003CN1431908A Kits and methods for optimizing efficacy of chondroprotective compsns.
07/23/2003CN1431907A Method of treating hepatitis delta viral infection
07/23/2003CN1431902A Therapeutic combinations of antihypertensive and antiangiogenic agents
07/23/2003CN1431894A Cosmetic compsn. comprising human serum albumin obtained from transgenic non-human animals
07/23/2003CN1431870A Compsns. contg. peptide and electrolyte excretion promoter and foods contg. same
07/23/2003CN1431864A Vaccines, immunotherapeutics and methods for using same
07/23/2003CN1431311A Method for expressing thymopolypeptides šŒ1 by use of escherichia coli and its application
1 ... 1807 1808 1809 1810 1811 1812 1813 1814 1815 1816 1817 1818 1819 1820 1821 1822 1823 1824 1825 1826 1827 ... 3163